Approvals/CIMA-AEMPS/QUOFENIX 300 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

Approved

STANDARD

QUOFENIX 300 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

A. Menarini Industrie Farmaceutiche Riunite S.R.L.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: fea4ace88f74ebc1
Drug Cima Aemps Name: QUOFENIX 300 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number: 1191393001
Holder Company Name: A. Menarini Industrie Farmaceutiche Riunite S.R.L.
Marketing Company Name: Laboratorios Menarini S.A.
Holder Company Detail Path: /organization/a-menarini-industrie-farmaceutiche-riunite-srl
Authorization Date: 2021-06-25
Dosage Form: POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 300 mg
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: A. Menarini Industrie Farmaceutiche Riunite S.R.L.
Company Detail Path: /organization/a-menarini-industrie-farmaceutiche-riunite-srl

DELAFLOXACINO MEGLUMINA

310 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jun 25, 2021

Approval ID

fea4ace88f74ebc1

Type

Standard